Last reviewed · How we verify
Active drug group — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Active drug group (Active drug group) — Tasly Pharmaceutical Group Co., Ltd. This is a broad category descriptor rather than a specific drug, referring to any pharmaceutical compound with active therapeutic properties marketed by Tasly Pharmaceutical Group.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Active drug group TARGET | Active drug group | Tasly Pharmaceutical Group Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Active drug group CI watch — RSS
- Active drug group CI watch — Atom
- Active drug group CI watch — JSON
- Active drug group alone — RSS
Cite this brief
Drug Landscape (2026). Active drug group — Competitive Intelligence Brief. https://druglandscape.com/ci/active-drug-group. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing